Aqsens Health’s board of directors strengthened with medtech industry expertise – An interview with Tuomo Pätsi
Aqsens Health is happy to announce that Mr. Tuomo Pätsi has been elected to Aqsens Health’s board of directors at Aqsens Health’s annual general meeting. Mr. Pätsi has over 30 years of experience in the medical industry, and he has led several biotech companies through successful market-entry and commercialization…
Time to put an end to TB – World Tuberculosis Day
Tuberculosis is a very complex health care problem that affects over 10 million people worldwide every year. It is treatable and curable, but still dangerous, especially to those with weakened immune systems…
Next practises and post-pandemic learnings for international research collaboration
Even a small company can greatly benefit from international collaborations, especially in the research and development phase. But why specifically should a health technology or biotechnology start-up look into the possibility of international collaboration?
If you set your mind to it, you can make it happen – Women and Girls in Science and Technology 2023
Every year the 11th of February is dedicated to the UN Day for Women and Girls in Science and Technology that recognizes the role of women in science, and encourages girls to pursue studies and careers in traditionally male-dominated fields. To celebrate the date, we had the opportunity to ask our friends and colleagues Elizabeth and Jasmine who work at the Noguchi Memorial Institute for Medical Research in Ghana about her studies and work in medical research.
Joining forces to create new innovative solutions – World Cancer Day 2023
The 2023 World Cancer Day continues the campaign to “Close the care gap”. This year the focus is on uniting our voices and joining forces to work together to achieve our goals and celebrate the big and small accomplishments in cancer care and research.
Tapping into the full potential of E-TRF and biosensors
Aqsens Health’s E-TRF method and its biochemical and chemical sensors are designed and developed to build a comprehensive view of the diseases at a low-cost, making large-scale screening a concrete possibility…
Aqsens Health and Equity Health Insurance sign a Memorandum of Understanding to deepen their collaboration in Ghana
Aqsens Health (Finland) and Equity Health Insurance (Ghana) signed a Memorandum of Understanding to accelerate market entry for AQ Malaria and other future tests for developing economies…
Updates from Ghana – Starting the E-TRF measurement of 2,800 malaria saliva samples
Aqsens Health and Noguchi Memorial Institute for Medical Research’s malaria screening test research project has been steadily moving ahead throughout 2022…
Using E-TRF to recognize deuterated compounds – Milja’s master’s thesis
Our Application Scientist Milja Virtanen finished her master’s thesis for Aqsens Health this autumn. Her MSc thesis in Chemistry focused on finding out if E-TRF can be used to differentiate between deuterated and non-deuterated compounds…
How E-TRF and biosensors can help reveal new disease biomarkers
Accurate detection of severe diseases typically requires more than just one biomarker and their discovery is exceptionally troublesome. Aqsens Health aims to speed up the process. Our E-TRF method, modulators and measurement protocols are able to detect groups of biomarkers in a single measurement from biological samples…
Roosa nauha 2022 – Huonoennusteiset syövät
Maria Veitolan suunnittelemassa vuoden 2022 Roosa nauhassa näkyvät rintasyövän vaaleanpunaisen lisäksi myös muiden syöpien tunnusvärit: eturauhassyövän vaaleansininen, lapsuudenajan syövän kultainen, keuhkosyövän valkoinen, sekä esimerkiksi usein vaikean haimasyövän violetti…
Elizabeth’s Finnish summer
After having spend a few months in training in Finland between February and March of this year, Elizabeth Cudjoe traveled to Finland again in the summer for some more in-depth training…
Aqsens Health and OG Pharmaceuticals partner for an upcoming collaborative research project – Interview with OG Pharmaceuticals Founder & CEO Dr. Zhao Wanzhou
Dr. Zhao answered shared his views about the upcoming collaboration with Aqsens Health, the benefits of urine-based detection, and applying new cancer screening solutions in China.
Aqsens Health and Turku University Hospital begin a project to assess a novel biosensor method for the early detection of metastatic cancers
Aqsens Health Oy begins a new research collaboration to assess the biosensor method in the detection of different metastatic cancers using urine samples. The BIOURICA research study brings together Aqsens Health Oy’s scientific team and the Turku University Hospital (TYKS) researcher, adjunct professor and Clinical Oncologist Maria Sundvall.
Aqsens Health and NMIMR on the path towards the commercialization of AQ Malaria
Aqsens Health received a meaningful contribution to its research and validation project in Ghana from the Finnpartnership business partnership program funded by the Ministry for Foreign Affairs of Finland.
Aqsens Health sharpens its focus around urinary tract diseases and starts looking into possibilities in the well-being sector.
Aqsens Health has decided to concentrate the company’s research on urine-based analysis, venturing further into the diagnostics of urologic and urinary tract conditions and well-being applications.
World Malaria Day 2022
Each year the 25th of April marks World Malaria Day. The day gives the world an opportunity to come together to highlight global efforts in malaria control, and to take concrete action to advance the fight against malaria. This year’s World Malaria Day theme is ‘Harness innovation to reduce the malaria disease burden and save lives’.
Cross-country skiing, sauna and mämmi – The Finland experience
Aqsens Health’s Ghana team – Sebastian, Jasmine and Elizabeth – completed their six week training and certification program in Finland at the end of March. For them, the weeks in Finland were filled with both theoretical and laboratory training, as well as sightseeing and experiencing the Finnish working culture and way of life.
Aqsens’ first E-TRF certification program successfully completed
Aqsens Health’s Ghana training team successfully completed AQH’s first E-TRF and biosensor training and certification program in Turku at the end of March. This is a major milestone for the company that’s expanding its international operations and preparing for a scale-up.
Striving to help change the world through malaria screening and management
Three researchers from the Noguchi Memorial Institute for Medical Research, Elizabeth Cudjoe, Jasmine Dowuona, and Sebastian Kwapong arrived in Finland from Ghana for their training on Valentine’s Day 2022.